Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
埃洛拉林肽(LY3841136),一种用于治疗肥胖症的新型胰淀素受体激动剂:从发现到临床概念验证
期刊:Molecular Metabolism
影响因子:6.6
doi:10.1016/j.molmet.2025.102271
Briere, Daniel A; Qu, Hongchang; Lansu, Katherine; He, Minxia Michelle; Moyers, Julie S; Coskun, Tamer; Long, Annie; Allen, Dawn; O'Farrell, Libbey; Bowen, Breanna; Pratt, Edward; Tidemann-Miller, Beth; Tham, Lai San; Ibriga, Hilda; Alsina-Fernandez, Jorge; Mather, Kieren J; Haupt, Axel; Bhattachar, Shobha N